Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 17.18 is 72% above its 5-year average of 9.99, near the high end of its 5-year range (-2.08–17.18).
156.80% above its 12-month average of 6.69.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
17.18
EARNINGS PER SHARE (EPS) AVG TTM
6.69
EARNINGS PER SHARE (EPS) AVG 3Y
10.10
EARNINGS PER SHARE (EPS) AVG 5Y
9.99
EARNINGS PER SHARE (EPS) AVG 10Y
6.46
EARNINGS PER SHARE (EPS) AVG 15Y
3.86
EARNINGS PER SHARE (EPS) AVG 20Y
2.27
CURRENT VS TTM AVG
+156.80%
CURRENT VS 3Y AVG
+70.10%
CURRENT VS 5Y AVG
+72.00%
CURRENT VS 10Y AVG
+166.02%
CURRENT VS 15Y AVG
+344.86%
CURRENT VS 20Y AVG
+656.67%
Vertex Pharmaceuticals Incorporated
Market Cap
$134.24B
Earnings Per Share (EPS)
17.18
TTM Avg
6.69
3Y Avg
10.10
5Y Avg
9.99
Market Cap
$132.14B
Earnings Per Share (EPS)
4.54
TTM Avg
-0.48
3Y Avg
1.47
5Y Avg
0.84
Market Cap
$144.25B
Earnings Per Share (EPS)
5.63
TTM Avg
5.20
3Y Avg
6.66
5Y Avg
6.73
Market Cap
$123.70B
Earnings Per Share (EPS)
8.79
TTM Avg
7.27
3Y Avg
5.84
5Y Avg
5.20
Market Cap
$122.58B
Earnings Per Share (EPS)
3.78
TTM Avg
2.53
3Y Avg
3.71
5Y Avg
4.39
Market Cap
$118.26B
Earnings Per Share (EPS)
4.06
TTM Avg
3.69
3Y Avg
3.25
5Y Avg
3.23
Market Cap
$105.97B
Earnings Per Share (EPS)
9.65
TTM Avg
8.18
3Y Avg
7.73
5Y Avg
6.75
Market Cap
$104.10B
Earnings Per Share (EPS)
37.37
TTM Avg
32.20
3Y Avg
28.04
5Y Avg
15.41
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | $134.24B | 17.18 | 6.69 | 10.10 | 9.99 |
| Bristol-Myers Squibb Company (BMY)vs › | $132.14B | 4.54 | -0.48 | 1.47 | 0.84 |
| Danaher Corporation (DHR)vs › | $144.25B | 5.63 | 5.20 | 6.66 | 6.73 |
| Intuitive Surgical, Inc. (ISRG)vs › | $123.70B | 8.79 | 7.27 | 5.84 | 5.20 |
| CVS Health Corp. (CVS)vs › | $122.58B | 3.78 | 2.53 | 3.71 | 4.39 |
| Medtronic plc (MDT)vs › | $118.26B | 4.06 | 3.69 | 3.25 | 3.23 |
| Pfizer Inc. (PFE)vs › | $158.39B | 0.76 | 1.39 | 2.19 | 2.39 |
| Stryker Corporation (SYK)vs › | $105.97B | 9.65 | 8.18 | 7.73 | 6.75 |
| McKesson Corporation (MCK)vs › | $104.10B | 37.37 | 32.20 | 28.04 | 15.41 |
| Sanofi (SNY)vs › | $103.62B | 0.56 | 3.01 | 2.95 | 3.44 |
Trailing EPS (TTM)
$17.18
Forward EPS (Est.)
$18.75
P/E Ratio
31.8
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 15.46 |
| 2024-12-31 | -2.08 |
| 2023-12-31 | 14.05 |
| 2022-12-31 | 12.97 |
| 2021-12-31 | 9.09 |
| 2020-12-31 | 10.44 |
| 2019-12-31 | 4.58 |
| 2018-12-31 | 8.25 |
| 2017-12-31 | 1.06 |
| 2016-12-31 | -0.46 |
| 2015-12-31 | -2.32 |
| 2014-12-31 | -3.14 |
| 2013-12-31 | -1.98 |
| 2012-12-31 | -0.50 |
| 2011-12-31 | 0.14 |
| 2010-12-31 | -3.77 |
| 2009-12-31 | -3.70 |
| 2008-12-31 | -3.27 |
| 2007-12-31 | -3.03 |
| 2006-12-31 | -1.83 |
| 2005-12-31 | -2.28 |
| 2004-12-31 | -2.12 |
| 2003-12-31 | -2.56 |
| 2002-12-31 | -1.43 |
| 2001-12-31 | -0.89 |
| 2000-12-31 | -0.59 |
| 1999-12-31 | -0.80 |
| 1998-12-31 | -0.65 |
| 1997-12-31 | -0.41 |
| 1996-12-31 | -1.07 |
Reported annual fiscal-period values; no daily interpolation.
